Quick Takeaways
- This page summarizes Jonathan E. Freeman's Form 4 filing for Phio Pharmaceuticals Corp. (PHIO).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 15 Sep 2025, 08:29.
Jonathan E. Freeman - 11 Sep 2025 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)
- Role
- Director
- Signature
- /s/ Lisa C. Carson, Attorney-in-Fact
- Issuer symbol
- PHIO
- Transactions as of
- 11 Sep 2025
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 15 Sep 2025, 08:29:41 UTC
- Previous filing
- 13 Sep 2024
- Next filing
- 06 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Jonathan E. Freeman filed Form 4 for Phio Pharmaceuticals Corp. (PHIO) on 15 Sep 2025."
What Changed
- Previous filing in this sequence was filed on 13 Sep 2024.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Freeman Jonathan E | Director | C/O PHIO PHARMACEUTICALS CORP., 411 SWEDELAND RD., STE 23-1080, KING OF PRUSSIA | /s/ Lisa C. Carson, Attorney-in-Fact | 15 Sep 2025 | 0001708133 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PHIO | Common Stock, $.0001 par value | Award | $0 | +14,700 | +1085% | $0.000000 | 16,055 | 11 Sep 2025 | Direct | F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant. |
| F2 | Includes shares of common stock underlying unvested restricted stock units. |
| F3 | The number of reported securities has been adjusted to reflect prior reverse stock splits. |
Remarks:
Exhibit 24 - Power of Attorney